share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Li Dean Y

SEC announcement ·  Jan 25 05:15
Summary by Futu AI
Li Dean Y, Executive VP & President of Merck & Co.'s MRL division, completed a purchase of 25,760 shares of the company's common stock on January 22, 2024. The transaction was carried out directly with the shares acquired at a price of $119.43 each. Following this acquisition, Li's total direct holdings in Merck & Co. amount to 46,242.37 shares. The transaction, which is categorized as a grant, award, or other acquisition, reflects a significant investment in the company by one of its top executives.
Li Dean Y, Executive VP & President of Merck & Co.'s MRL division, completed a purchase of 25,760 shares of the company's common stock on January 22, 2024. The transaction was carried out directly with the shares acquired at a price of $119.43 each. Following this acquisition, Li's total direct holdings in Merck & Co. amount to 46,242.37 shares. The transaction, which is categorized as a grant, award, or other acquisition, reflects a significant investment in the company by one of its top executives.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.